230 related articles for article (PubMed ID: 19276665)
1. Vaccines for cocaine abuse.
Orson FM; Kinsey BM; Singh RA; Wu Y; Kosten TR
Hum Vaccin; 2009 Apr; 5(4):194-9. PubMed ID: 19276665
[TBL] [Abstract][Full Text] [Related]
2. Anti-cocaine vaccines: antibody protection against relapse.
Kantak KM
Expert Opin Pharmacother; 2003 Feb; 4(2):213-8. PubMed ID: 12562311
[TBL] [Abstract][Full Text] [Related]
3. Substance abuse vaccines.
Orson FM; Kinsey BM; Singh RA; Wu Y; Gardner T; Kosten TR
Ann N Y Acad Sci; 2008 Oct; 1141():257-69. PubMed ID: 18991962
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy.
Dickerson TJ; Kaufmann GF; Janda KD
Expert Opin Biol Ther; 2005 Jun; 5(6):773-81. PubMed ID: 15952908
[TBL] [Abstract][Full Text] [Related]
5. Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
Havlicek DF; Rosenberg JB; De BP; Hicks MJ; Sondhi D; Kaminsky SM; Crystal RG
PLoS One; 2020; 15(11):e0239780. PubMed ID: 33253224
[TBL] [Abstract][Full Text] [Related]
6. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.
Hall W; Carter L
J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512
[TBL] [Abstract][Full Text] [Related]
7. The future potential for cocaine vaccines.
Orson FM; Wang R; Brimijoin S; Kinsey BM; Singh RA; Ramakrishnan M; Wang HY; Kosten TR
Expert Opin Biol Ther; 2014 Sep; 14(9):1271-83. PubMed ID: 24835496
[TBL] [Abstract][Full Text] [Related]
8. Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice.
Brimijoin S; Orson F; Kosten TR; Kinsey B; Shen XY; White SJ; Gao Y
Chem Biol Interact; 2013 Mar; 203(1):212-6. PubMed ID: 22960160
[TBL] [Abstract][Full Text] [Related]
9. [Vaccines against substance abuse].
Mørland J
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2974-6. PubMed ID: 17117198
[No Abstract] [Full Text] [Related]
10. The future of vaccines in the management of addictive disorders.
Orson FM; Kinsey BM; Singh RA; Wu Y; Gardner T; Kosten TR
Curr Psychiatry Rep; 2007 Oct; 9(5):381-7. PubMed ID: 17915077
[TBL] [Abstract][Full Text] [Related]
11. Vaccine pharmacotherapy for the treatment of cocaine dependence.
Martell BA; Mitchell E; Poling J; Gonsai K; Kosten TR
Biol Psychiatry; 2005 Jul; 58(2):158-64. PubMed ID: 16038686
[TBL] [Abstract][Full Text] [Related]
12. Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus.
Koob G; Hicks MJ; Wee S; Rosenberg JB; De BP; Kaminsky SM; Moreno A; Janda KD; Crystal RG
CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):899-904. PubMed ID: 22229312
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic vaccines for substance dependence.
Kosten TR; Biegel D
Expert Rev Vaccines; 2002 Oct; 1(3):363-71. PubMed ID: 12901575
[TBL] [Abstract][Full Text] [Related]
14. Vaccines against stimulants: cocaine and MA.
Kosten T; Domingo C; Orson F; Kinsey B
Br J Clin Pharmacol; 2014 Feb; 77(2):368-74. PubMed ID: 23509915
[TBL] [Abstract][Full Text] [Related]
15. Suppression of psychoactive effects of cocaine by active immunization.
Carrera MR; Ashley JA; Parsons LH; Wirsching P; Koob GF; Janda KD
Nature; 1995 Dec; 378(6558):727-30. PubMed ID: 7501020
[TBL] [Abstract][Full Text] [Related]
16. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.
Brimijoin S; Shen X; Orson F; Kosten T
Expert Rev Vaccines; 2013 Mar; 12(3):323-32. PubMed ID: 23496671
[TBL] [Abstract][Full Text] [Related]
17. Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody.
Norman AB; Ball WJ
Immunotherapy; 2012 Mar; 4(3):335-43. PubMed ID: 22401638
[TBL] [Abstract][Full Text] [Related]
18. Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter.
Ashcroft RE; Franey C
J Med Ethics; 2004 Aug; 30(4):341-3. PubMed ID: 15289513
[TBL] [Abstract][Full Text] [Related]
19. Immunization for prevention and treatment of cocaine abuse: legal and ethical implications.
Cohen PJ
Drug Alcohol Depend; 1997 Dec; 48(3):167-74. PubMed ID: 9449015
[TBL] [Abstract][Full Text] [Related]
20. AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.
Rosenberg JB; Hicks MJ; De BP; Pagovich O; Frenk E; Janda KD; Wee S; Koob GF; Hackett NR; Kaminsky SM; Worgall S; Tignor N; Mezey JG; Crystal RG
Hum Gene Ther; 2012 May; 23(5):451-9. PubMed ID: 22486244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
